Skip to main content
OpenTrials
Completed

NCT Number: NCT02581566

Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy

Comparison between intrathecal Dexmedetomidine versus Intraarticular Dexmedetomidine on postoperative pain after knee arthroscopy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Assiut University Hospital

Asyut, 71515, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients, ASA I-II, undergoing knee arthroscopy under spinal anesthesia.

Exclusion criteria

  • Absolute or relative contraindications to spinal anesthesia, allergy to dexmedetomidine or chronic pain treatment.

Treatment and study plan

Intrathecal dexmedetomidine

Drug

Addition of Intathecal Dexmedetomidine plus Intrathecal Bupivacaine

Intraarticular Dexmedetomidine

Drug

Addition of Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine

Bupivacaine

Drug

Intrathecal Bupivacaine

Primary outcomes

  1. postoperative pain

    Time frame: 24 hours

    Assesment is done by Visual Analog Scale

Secondary outcomes

  1. c-reactive protein

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Oct 21, 2015
Registry last updated
Mar 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.